| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0090-6980(83)90099-0 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0090698083900990?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0090698083900990?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 6316421 |
| P2093 | author name string | R. A. Johnson | |
| R. R. Gorman | |||
| C. H. Spilman | |||
| J. W. Aiken | |||
| P2860 | cites work | Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin | Q40682963 |
| Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2 | Q43630252 | ||
| Analysis of the biological activity of azoprostanoids in human platelets | Q67301002 | ||
| Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization | Q67602359 | ||
| A radioimmunoassay for thromboxane B2 | Q67683076 | ||
| Selective inhibitor of thromboxane synthetase: pyridine and its derivatives | Q70649282 | ||
| Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin) | Q72137945 | ||
| Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase | Q72458471 | ||
| Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis | Q72909332 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| endocrinology | Q162606 | ||
| P304 | page(s) | 325-342 | |
| P577 | publication date | 1983-08-01 | |
| P1433 | published in | Prostaglandins | Q24054793 |
| P1476 | title | Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate | |
| Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate | |||
| P478 | volume | 26 |
| Q36004452 | A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats |
| Q41533935 | A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies |
| Q36108052 | Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets |
| Q36415871 | Inhibition of thromboxane a synthase activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells |
| Q41818575 | Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo |
| Q44922978 | Multiple dose trial of the thromboxane synthase inhibitor furegrelate in normal subjects |
| Q43116223 | NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities |
| Q38525064 | Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism |
| Q53789207 | Pharmacokinetics of furegrelate after oral administration to normal humans. |
| Q35593380 | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis |
| Q47174000 | Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist |
| Q43653888 | Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats |
| Q44410745 | Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats |
| Q44164049 | Roles of brain prostaglandin E2 and thromboxane A2 in the activation of the central sympatho-adrenomedullary outflow in rats |
| Q48403311 | Thromboxane A2 is involved in the nitric oxide-induced central activation of adrenomedullary outflow in rats |
| Q37953820 | Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting. |
| Q44134461 | Thromboxane A2 synthase. Modification during “suicide” inactivation |
| Q41169837 | Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent |
Search more.